DRUG FACTS

Manufacturer
Tejeda Enterprises Incorporated
Effective date
2026-08-15
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
daily-update
Hydrated at
2026-08-18 02:02:22

Label at a glance#

ProductRegenarX
Active ingredientTEA TREE OIL, EUGENIA CARYOPHYLLUS (CLOVE) STEM OIL, ARNICA MONTANA ROOT, AZADIRACHTA INDICA SEED OIL, RICINUS COMMUNIS (CASTOR) SEED OIL, HYPERICUM OIL
Label structure8 sections

Indications and uses

SCIATICA, BURNS, BRUISES, JOINT AND MUSCLE PAIN, SCAR TISSUE, INFLAMMATION, ARTHRITIS, FIBROMYALGIA, HEMORRHOIDS. TOPICAL SOLUTION FOR PAIN AND WOUNDS

Label contents#

Full prescribing information#

DRUG FACTS

OTC - ACTIVE INGREDIENT SECTION

DIRECTIONS: For topical application only. Apply generously to the affected area twice daily. Wash hands thoroughly after use. Can be used on children in small doses when applied by an adult. DRUG FACTS OTHER INFORMATION Store at room temperature: 15° —30° C (59° - 86° F)
DRUG FACTS WARNINGS Do not • use In the eyes • use on individuals who are allergic or sensitive to ingredients • apply over large areas of the body Discontinue use and ask a doctor • if condition persists or gets worse • for use longer than 1 week Ask a doctor in case of • deep or puncture wounds • animal bites • serious burns Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center.
TOPICAL SOLUTION FOR PAIN & WOUND CARE

DOSAGE & ADMINISTRATION SECTION

DIRECTIONS: For topical application only. Apply generously to the affected area twice daily. Wash hands thoroughly after use. Can be used on children in small doses when applied by an adult.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

SCIATICA, BURNS, BRUISES, JOINT AND MUSCLE PAIN, SCAR TISSUE, INFLAMMATION, ARTHRITIS, FIBROMYALGIA, HEMORRHOIDS. TOPICAL SOLUTION FOR PAIN AND WOUNDS

Purpose

OTC - PURPOSE SECTION

Reduce inflammation, reduce scar tissue, heal burns, reduce pain for arthritis and fibromyalgia

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

ARGANIA SPINOSA KERNEL OIL

WARNINGS SECTION

Do not • use In the eyes • use on individuals who are allergic or sensitive to ingredients • apply over large areas of the body Discontinue use and ask a doctor • if condition persists or gets worse • for use longer than 1 week Ask a doctor in case of • deep or puncture wounds • animal bites • serious burns Keep out of reach of children. If swallowed, get medical help or contact the Poison Control Center right away.
Do not use on open wounds. For external use only. Keep out of reach of children.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Principal Display PanelPrincipal Display Panel

Principal Display Panel

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84761-000884761-0008-4

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
12026-07-06weekly-update2026-07-17 21:43:53

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RegenarXCASTORTejeda Enterprises Incorporated55f75e79-da6a-d91b-e063-6294a90afee12026-08-15WarningsExact identifier
ndc (package): 84761-0008-4
ndc (product): 84761-0008
ndc11 (package): 84761000804
spl id: 590f4598-cde2-ae44-e063-6394a90a0454
spl set id: 55f75e79-da6a-d91b-e063-6294a90afee1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.